Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Molecular Diagnostics

Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

An AI approach using single-cell RNA-seq maps lung tumors to predict outcomes and metastasis risk beyond staging. More...
16 Nov 2026
Image: Researchers developed a blood test that accurately distinguishes early-stage breast cancer from healthy controls and may outperform tissue biopsy in predicting recurrence risk (Image Credit: Adobe Stock)

Epigenetic Blood Test Detects Early Breast Cancer and Predicts Recurrence Risk

A new blood-based epigenetic test detects early breast cancer with 95% accuracy and predicts recurrence risk. More...
16 Nov 2026
Image: Unlike conventional molecular methods, VedaBio\'s CRISPR-based technology detects targets without requiring amplification (Photo courtesy of Veda Bio)

Target-Amplification-Free CRISPR Platform Demonstrates Molecular Detection in Under 10 Minutes

VedaBio presented proof-of-concept data for its integrated, target amplification-free CRISPR-based molecular diagnostics platform at AMP 2026 More...
16 Nov 2026
Image Credit: iStock

Fapon Showcases AI-Engineered Enzymes and RNA Workflows at AMP 2026

Fapon showcased its AI-engineered enzymes, reverse transcription technologies, and nucleic acid library preparation solutions at the AMP 2026, More...
16 Nov 2026
Image Credit: iStock

AMP 2026 Underscores Molecular Testing’s Role in Precision Medicine for Women’s Health

Among the research presented at AMP 2026 were two studies on antimicrobial resistance in STIs and molecular risk stratification in endometrial cancer. More...
16 Nov 2026
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Several AMP 2026 studies highlight AI’s potential in molecular pathology while addressing reliability, validation, and expert oversight. More...
13 Nov 2026
Image: Together, the AMP 2026 studies highlight the expanding role of molecular diagnostics in genetic disease detection, pediatric cancer classification, and infectious disease surveillance. (Image Credit: Adobe Stock)

AMP 2026 Highlights Advances in Molecular Testing for Pediatric Diseases

The AMP 2026 Annual Meeting & Expo features six studies on genetic disease detection, pediatric oncology, and infectious disease surveillance. More...
13 Nov 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.